Follow the LEADER—Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Follow the LEADER—Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial ; day:9 ; month:9 ; year:2016 ; pages:1-9
Diabetes therapy ; (9.9.2016), 1-9
- Urheber
-
Kalra, Sanjay
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-016-0197-4
- URN
-
urn:nbn:de:1111-201610108388
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kalra, Sanjay
- SpringerLink (Online service)
Ähnliche Objekte (12)
Equipoise Is a Slippery Eel
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Mishti copes with diabetes: A pragmatic approach to coping skills training
Diabetes: Exploring social and psychological domain
Mishti copes with diabetes: Dancing
Higher, sweeter, heavier: Not necessarily healthier
Discrimination and diabetes: Insight from the second Diabetes Attitudes Wishes and Needs (DAWN2) Study
Therapy in type 2 diabetes: A logical empiricism - based approach
The alcohol and tobacco burden of India
Erratum to: Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Equipoise Is a Slippery Eel
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Mishti copes with diabetes: A pragmatic approach to coping skills training
Diabetes: Exploring social and psychological domain
Mishti copes with diabetes: Dancing
Higher, sweeter, heavier: Not necessarily healthier
Discrimination and diabetes: Insight from the second Diabetes Attitudes Wishes and Needs (DAWN2) Study
Therapy in type 2 diabetes: A logical empiricism - based approach
The alcohol and tobacco burden of India
Erratum to: Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Equipoise Is a Slippery Eel
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Mishti copes with diabetes: A pragmatic approach to coping skills training
Diabetes: Exploring social and psychological domain
Mishti copes with diabetes: Dancing
Higher, sweeter, heavier: Not necessarily healthier
Discrimination and diabetes: Insight from the second Diabetes Attitudes Wishes and Needs (DAWN2) Study
Therapy in type 2 diabetes: A logical empiricism - based approach
The alcohol and tobacco burden of India